Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Change in Acquisitions & Divestments (2022 - 2025)

CervoMed's Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $11.5 million for Q3 2025.

  • For Q3 2025, Change in Acquisitions & Divestments rose 76.92% year-over-year to $11.5 million; the TTM value through Sep 2025 reached $46.4 million, up 614.46%, while the annual FY2024 figure was $19.4 million, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q3 2025 was $11.5 million at CervoMed, up from $9.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $12.9 million in Q4 2024 and bottomed at -$12.5 million in Q3 2023.
  • The 4-year median for Change in Acquisitions & Divestments is $9.5 million (2023), against an average of $7.2 million.
  • The largest annual shift saw Change in Acquisitions & Divestments plummeted 228.21% in 2023 before it skyrocketed 152.0% in 2024.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $7.0 million in 2022, then plummeted by 278.57% to -$12.5 million in 2023, then surged by 203.52% to $12.9 million in 2024, then dropped by 11.13% to $11.5 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Change in Acquisitions & Divestments are $11.5 million (Q3 2025), $9.5 million (Q2 2025), and $12.5 million (Q1 2025).